We are live on ! Find out more
BJ

BlackRock Japan Portfolio holdings

AUM $30.3B
1-Year Est. Return 13.85%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+13.85%
3 Year Est. Return
+34.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.9B
AUM Growth
+$847M
Cap. Flow
+$915M
Cap. Flow %
3.53%
Top 10 Hldgs %
15.93%
Holding
1,488
New
193
Increased
660
Reduced
416
Closed
148

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$32.9M
2
AAPL icon
Apple
AAPL
+$29.5M
3
SLB icon
SLB Ltd
SLB
+$27.3M
4
CFG icon
Citizens Financial Group
CFG
+$25.8M
5
CSCO icon
Cisco
CSCO
+$25.8M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$53.5M
2
BA icon
Boeing
BA
+$25.7M
3
NWL icon
Newell Brands
NWL
+$22.6M
4
HCA icon
HCA Healthcare
HCA
+$22.4M
5
PCYC
PHARMACYCLICS INC
PCYC
+$19.7M

Sector Composition

Rank Sector Weight
1 Healthcare 15.93%
2 Financials 14.51%
3 Technology 14.34%
4 Industrials 9.28%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADC icon
1176
Agree Realty
ADC
$9.69B
$23K ﹤0.01%
797
+5
+0.6% +$155
CADE
1177
DELISTED
Cadence Bank
CADE
$23K ﹤0.01%
874
-946
-52% -$23.3K
CPRX
1178
DELISTED
Catalyst Pharmaceutical
CPRX
$23K ﹤0.01%
+5,522
New +$22K
PTCT icon
1179
PTC Therapeutics
PTCT
$6.25B
$23K ﹤0.01%
476
+155
+48% +$9.04K
TVRD
1180
Tvardi Therapeutics
TVRD
$22.2M
$23K ﹤0.01%
+53
New +$20.5K
VOLT
1181
DELISTED
Volt Information Sciences, Inc.
VOLT
$23K ﹤0.01%
+2,330
New +$26.2K
BSTC
1182
DELISTED
BioSpecifics Technologies Corp.
BSTC
$23K ﹤0.01%
437
-739
-63% -$31.5K
PTLA
1183
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$23K ﹤0.01%
496
+353
+247% +$14.2K
OSIR
1184
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$23K ﹤0.01%
1,157
+531
+85% +$9.4K
ASPN icon
1185
Aspen Aerogels
ASPN
$349M
$22K ﹤0.01%
+3,339
New +$22.8K
UGI icon
1186
UGI
UGI
$7.85B
$22K ﹤0.01%
625
-12,920
-95% -$458K
UHT
1187
Universal Health Realty Income Trust
UHT
$624M
$22K ﹤0.01%
464
-31
-6% -$1.54K
MTEM
1188
DELISTED
Molecular Templates, Inc.
MTEM
$22K ﹤0.01%
+33
New +$21.8K
KDNY
1189
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$22K ﹤0.01%
+148
New +$24.4K
CDR
1190
DELISTED
Cedar Realty Trust, Inc
CDR
$22K ﹤0.01%
513
+15
+3% +$688
GNCA
1191
DELISTED
Genocea Biosciences, Inc.
GNCA
$22K ﹤0.01%
197
-230
-54% -$21.4K
IOVA icon
1192
Iovance Biotherapeutics
IOVA
$2.1B
$21K ﹤0.01%
2,241
-1,141
-34% -$12.7K
RIGL icon
1193
Rigel Pharmaceuticals
RIGL
$735M
$21K ﹤0.01%
+649
New +$24.8K
TKC icon
1194
Turkcell
TKC
$4.73B
$21K ﹤0.01%
1,813
– –
TRVN
1195
DELISTED
Trevena, Inc.
TRVN
$21K ﹤0.01%
5
-4
-44% -$16.9K
SSI
1196
DELISTED
Stage Stores Inc
SSI
$21K ﹤0.01%
1,217
-1,806
-60% -$34.2K
NCIT
1197
DELISTED
NCI, Inc.
NCIT
$21K ﹤0.01%
+2,066
New +$21.7K
HILL
1198
DELISTED
DOT HILL SYSTEMS CORP
HILL
$21K ﹤0.01%
+3,464
New +$23.1K
UBA
1199
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$21K ﹤0.01%
1,145
-75
-6% -$1.54K
IRMD icon
1200
iRadimed
IRMD
$1.22B
$20K ﹤0.01%
+847
New +$15.5K
46 47
48
49 50

Similar funds

IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return
WC
Weatherbie Capital Boston, Massachusetts $797M AUM 23.31% 1-Year Est. Return
BWM
Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

BlackRock Japan's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Japan held 1,488 positions worth $25.9B, up 3.4% from $25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BlackRock Japan deployed $915M of net new capital in Q2 2015, opening 193 new positions and adding to 660 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 70,712 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Boeing, an estimated $25.7M trimmed.

  • BlackRock Japan's largest Q2 2015 buy was Jazz Pharmaceuticals: 70,712 shares worth $12.4M.
  • BlackRock Japan added most to Johnson & Johnson in Q2 2015, an estimated $32.9M increase.
  • BlackRock Japan's biggest Q2 2015 reduction was Boeing, cutting an estimated $25.7M.
  • BlackRock Japan fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $53.5M.
  • BlackRock Japan's ten largest holdings make up 16% of its $25.9B portfolio in Q2 2015.
  • BlackRock Japan opened 193 new positions and closed 148 in Q2 2015.
  • BlackRock Japan's portfolio value rose 3.4% quarter-over-quarter to $25.9B.

Based on BlackRock Japan's 13F filing for Q2 2015, filed 7 Aug 2015.